{
    "nctId": "NCT05440929",
    "briefTitle": "Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians",
    "officialTitle": "Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians",
    "overallStatus": "RECRUITING",
    "conditions": "Metastatic Breast Cancer, End of Life",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 15,
    "primaryOutcomeMeasure": "Key barriers for use a metastatic breast cancer-specific prognostic tool",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Verbal informed consent obtained to participate in the study.\n2. Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.\n3. Physician, nurse practitioner, physician assistant, or nurse navigator\n4. At least 6 months of experience in the clinical care of patients with metastatic breast cancer in the United States.\n\nExclusion Criteria:\n\n* Non-English Speaking",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}